vs

Side-by-side financial comparison of INVO Fertility, Inc. (IVF) and Functional Brands Inc. (MEHA). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $1.7M, roughly 1.0× Functional Brands Inc.). Functional Brands Inc. runs the higher net margin — 15.3% vs -150.5%, a 165.8% gap on every dollar of revenue. Functional Brands Inc. produced more free cash flow last quarter ($1.5M vs $-1.8M).

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

Fortune Brands Innovations, Inc. is an American manufacturer of home and security products, headquartered in Deerfield, Illinois. Its portfolio of businesses and brands includes Moen and the House of Rohl; outdoor living and security products from Therma-Tru, Larson, Fiberon, Master Lock and SentrySafe; and MasterBrand Cabinets. Fortune Brands is a Fortune 500 company and part of the S&P 400 Index. As of December 31, 2021, the company reported employing approximately 28,000 associates and pos...

IVF vs MEHA — Head-to-Head

Bigger by revenue
IVF
IVF
1.0× larger
IVF
$1.8M
$1.7M
MEHA
Higher net margin
MEHA
MEHA
165.8% more per $
MEHA
15.3%
-150.5%
IVF
More free cash flow
MEHA
MEHA
$3.3M more FCF
MEHA
$1.5M
$-1.8M
IVF

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
IVF
IVF
MEHA
MEHA
Revenue
$1.8M
$1.7M
Net Profit
$-2.6M
$259.0K
Gross Margin
57.7%
Operating Margin
-93.1%
-4.6%
Net Margin
-150.5%
15.3%
Revenue YoY
22.6%
Net Profit YoY
-62.2%
EPS (diluted)
$-0.77
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVF
IVF
MEHA
MEHA
Q3 25
$1.8M
$1.7M
Q2 25
$1.9M
Q1 25
$1.6M
Q4 24
$1.7M
Q3 24
$1.4M
Q2 24
$1.8M
Q1 24
$1.6M
Q4 23
$1.4M
Net Profit
IVF
IVF
MEHA
MEHA
Q3 25
$-2.6M
$259.0K
Q2 25
$-5.3M
Q1 25
$-17.4M
Q4 24
$-3.6M
Q3 24
$-1.6M
Q2 24
$-2.2M
Q1 24
$-1.6M
Q4 23
$-2.0M
Gross Margin
IVF
IVF
MEHA
MEHA
Q3 25
57.7%
Q2 25
Q1 25
35.2%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
53.1%
Q1 24
45.3%
Q4 23
33.0%
Operating Margin
IVF
IVF
MEHA
MEHA
Q3 25
-93.1%
-4.6%
Q2 25
-160.4%
Q1 25
-1042.1%
Q4 24
-202.0%
Q3 24
-90.7%
Q2 24
-100.9%
Q1 24
-95.7%
Q4 23
-109.2%
Net Margin
IVF
IVF
MEHA
MEHA
Q3 25
-150.5%
15.3%
Q2 25
-283.6%
Q1 25
-1060.1%
Q4 24
-211.3%
Q3 24
-113.8%
Q2 24
-122.2%
Q1 24
-101.3%
Q4 23
-144.4%
EPS (diluted)
IVF
IVF
MEHA
MEHA
Q3 25
$-0.77
$0.04
Q2 25
$-13.30
Q1 25
$-12.53
Q4 24
$14.86
Q3 24
$-15.11
Q2 24
$-22.39
Q1 24
$-7.55
Q4 23
$-59.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVF
IVF
MEHA
MEHA
Cash + ST InvestmentsLiquidity on hand
$1.0M
Total DebtLower is stronger
$2.0M
$141.3K
Stockholders' EquityBook value
$5.8M
$604.7K
Total Assets
$18.8M
$8.2M
Debt / EquityLower = less leverage
0.34×
0.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVF
IVF
MEHA
MEHA
Q3 25
$1.0M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Total Debt
IVF
IVF
MEHA
MEHA
Q3 25
$2.0M
$141.3K
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Q4 23
Stockholders' Equity
IVF
IVF
MEHA
MEHA
Q3 25
$5.8M
$604.7K
Q2 25
$2.6M
Q1 25
$3.3M
Q4 24
$12.7M
Q3 24
$-23.3K
Q2 24
$1.4M
Q1 24
$10.2K
Q4 23
$892.8K
Total Assets
IVF
IVF
MEHA
MEHA
Q3 25
$18.8M
$8.2M
Q2 25
$19.3M
Q1 25
$31.7M
Q4 24
$46.4M
Q3 24
$17.0M
Q2 24
$17.8M
Q1 24
$17.3M
Q4 23
$18.5M
Debt / Equity
IVF
IVF
MEHA
MEHA
Q3 25
0.34×
0.23×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVF
IVF
MEHA
MEHA
Operating Cash FlowLast quarter
$-1.8M
$1.5M
Free Cash FlowOCF − Capex
$-1.8M
$1.5M
FCF MarginFCF / Revenue
-101.6%
86.8%
Capex IntensityCapex / Revenue
0.5%
0.5%
Cash ConversionOCF / Net Profit
5.71×
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVF
IVF
MEHA
MEHA
Q3 25
$-1.8M
$1.5M
Q2 25
$-1.7M
Q1 25
$-3.5M
Q4 24
$-617.4K
Q3 24
$-640.8K
Q2 24
$-1.5M
Q1 24
$-260.6K
Q4 23
$-714.9K
Free Cash Flow
IVF
IVF
MEHA
MEHA
Q3 25
$-1.8M
$1.5M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-696.3K
Q3 24
Q2 24
$-1.5M
Q1 24
$-310.3K
Q4 23
FCF Margin
IVF
IVF
MEHA
MEHA
Q3 25
-101.6%
86.8%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-40.6%
Q3 24
Q2 24
-82.3%
Q1 24
-19.7%
Q4 23
Capex Intensity
IVF
IVF
MEHA
MEHA
Q3 25
0.5%
0.5%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
4.6%
Q3 24
0.0%
Q2 24
3.0%
Q1 24
3.2%
Q4 23
Cash Conversion
IVF
IVF
MEHA
MEHA
Q3 25
5.71×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons